Table 2.
Cancer Type | Cellular Source | Vesicular Cargo | The Main Result | Refs. |
---|---|---|---|---|
Triple-negative breast cancer | MDA-MB-231 BT-20 MDA-MB-453 MCF7 BT-474 SK-BR-3 |
ITGB4 proteins | Enhanced mitophagy and lactate generation in CAFs in a BNIP3L-dependent manner. | [64] |
TNBC MDA-MB-231 MDA-MB-468 |
miR-9 | Influenced the properties of NFs and promoted the switch to CAF, thereby leading to tumor growth. | [58] | |
Ovarian cancer | A2780 SKVO3 |
miR-630 | Raised amounts of α-SMA and FAP in NFs resulted in the differentiation of NFs into CAFs via inhibiting KLF6 and activating the NFκB pathway. | [60] |
Bladder cancer | RT4 T24 SW1710 |
TGF-β | Triggered the differentiation of fibroblasts to CAFs by SMAD pathway activation | [63] |
Colorectal cancer | SW620 SW480 |
Vesicular cargo | Activated normal quiescent fibroblasts (α-SMA−, CAV+) into CAF-like fibroblasts (α-SMA+, CAV−) with pro-proliferative and pro-angiogenic features | [65] |
Lung cancer (LC) | A549 H460 |
miR-210 | Promoted the NFs transferring into CAFs via activating JAK2/STAT3 pathway, and ten-eleven translocation 2 (TET2) | [61] |
Melanoma | B16BL6 | eTGF-β | Triggered TGF-β signaling in HUVECs and differentiated them into CAFs | [19] |
B16F0 | Gm26809 | Stimulated conversion of fibroblast NIH3T3 cells into CAFs | [66] | |
B16-F10 | miR-21 | Stimulated invasiveness of fibroblasts by increasing matrix metalloprotein (MMP) and down-regulation of tissue inhibitor of metalloproteinase 3 (TIMP3) expressions. | [59] | |
Breast cancer | MCF-7 MDA-MB-231 |
Vesicular survivin | Converted NFs into myofibroblasts by upregulating SOD1 and increased proliferation, EMT, and stemness. | [62] |
Head and neck squamous cell carcinoma (HNSCC) | SAS HSC-3 |
Vesicular cargo | Convert normal fibroblasts into CAF-like cells and raised fibroblast proliferation, migration and activation of 11 signaling pathways (IL-6- and IL-17-related signaling) | [67] |